TCTMD’s Top 10 Most Popular Stories for March 2020
No surprise: COVID-19 dominated the top 10 list this month, revealing just how much the world changed in a few short weeks.
Unsurprisingly, COVID-19 dominated TCTMD’s most popular news in March 2020. The different topics that made the list speak to how quickly the world changed in a few short weeks. At the start of the month it seemed likely that the American College of Cardiology/World Congress of Cardiology meeting would likely still go ahead; by the end of March, that optimism looks laughable given the stories pouring in from other hard-hit countries. The only outlier in the top 10 this month—let’s call it a “good news story”—was a study looking at olive oil consumption and its potential to reduce cardiovascular disease in the US.
As COVID-19 cases go global, a picture is emerging as to its CV impact and how cardiologists in hard-hit regions are coping.
Be prepared, experts urge. Much is still unknown about how the novel coronavirus will affect day-to-day and emergency CVD care.
Experts stress there is not enough evidence to suggest these medications can worsen COVID-19 morbidity and mortality.
Americans tend to consume far less olive oil than their Mediterranean counterparts, but beneficial signals are still seen.
“You wouldn’t send a soldier into war without a gun or body armor,” one doctor says. Front-line physicians offer some tips.
More research is needed, but for now, there’s no evidence that background use of the agents harms or helps in COVID-19.
It’s a wise move, Mamas Mamas says, both for the health of the attendees and for the patients they care for back home.
Wuhan researchers have published details on 416 hospitalized patients, but treatment pathways remain unclear.
One piece of advice is to not overlook classic symptoms and presentation of acute MI in the context of COVID-19.
The new, detailed guidance does not amount to “hard and fast rules.” SCAI says hospitals need to make case-by-case decisions.